Anzeige
Mehr »
Montag, 28.07.2025 - Börsentäglich über 12.000 News
Warum Analysten in diesem veganen Gamechanger viel mehr sehen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C017 | ISIN: FR0010907956 | Ticker-Symbol: CXT
Frankfurt
28.07.25 | 17:15
0,288 Euro
+5,31 % +0,015
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CARMAT Chart 1 Jahr
5-Tage-Chart
CARMAT 5-Tage-Chart
RealtimeGeldBriefZeit
0,3300,35020:14
0,6300,68004.07.

Aktuelle News zur CARMAT Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18:18PARIS - CARMAT's Aeson artificial heart receives MDR CE marking2
18:06CARMAT Receives MDR CE Marking for Its Aeson Artificial Heart138Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
03.07.CARMAT Announces the Initiation of a Call for Public Tenders (Buyers or Investors) as Part of the Receivership Procedure389Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
02.07.XFRA CXT: WIEDERAUFNAHME/RESUMPTION185FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
01.07.Carmat files for insolvency10
CARMAT Aktie jetzt für 0€ handeln
01.07.CARMAT Announces Its Placement in Receivership Procedure295Resumption of CARMAT shares trading starting July 2, 2025, at stock market opening Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial...
► Artikel lesen
30.06.XFRA CXT: AUSSETZUNG/SUSPENSION192DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCARMAT EO -,04 CXT...
► Artikel lesen
30.06.CARMAT Announces Filing Today for Insolvency and Requesting Being Placed in Receivership427Suspension of CARMAT shares trading starting June 30, 2025, before stock market opening Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total...
► Artikel lesen
24.06.Carmat is running out of cash5
20.06.In a Context of Critical Financial Situation, CARMAT Launches a Donation Campaign Open to All to Contribute to Its Funding and Continuation of Its Activities370Risk of insolvency as early as end of June 2025 Launch of a donation campaign open to all via the onparticipe.fr online platform To listen to CARMAT CEO's message, click here Regulatory...
► Artikel lesen
20.06.CARMAT Announces Being in a Critical Financial Situation and at Risk of Insolvency as of End-June 2025442Immediate need to secure approximately €3.5 million to avoid insolvency at the end of June 2025 Total funding needs of around €35 million over the next 12 months Ongoing active exploration...
► Artikel lesen
02.06.CARMAT Announces the First Commercial Implants of Its Aeson Artificial Heart Outside the European Union380Two implants have recently been performed in Israel Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide...
► Artikel lesen
12.05.CARMAT Completes Enrolment in the EFICAS Clinical Study and Receives Approval From French Authorities for 21 Additional Aeson Implants, While Awaiting Potential Reimbursement of the Device in France288Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
30.04.CARMAT: Availability of the 2024 Universal Registration Document374Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
29.04.CARMAT Announces Its 2024 Annual Results470Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
14.04.CARMAT Receives FDA Conditional Approval to Initiate the Second Cohort of the EFS Study in the United States310Recruitment of the second cohort expected to begin in H2 2025 Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming...
► Artikel lesen
09.04.CARMAT Delivers Q1 2025 Results in Line With Its Objectives311Quarterly sales of €2.4m multiplied by 2.4 vs Q1 2024 EFICAS clinical trial recruitment 94% complete 2 scientific publications a strong driver of Aeson® adoption Final stage...
► Artikel lesen
03.04.CARMAT - Publication in the JACC(1): Heart Failure of the Initial Clinical Experience with Aeson Total Artificial Heart in Cardiogenic Shock Patients Initially Placed on Extracorporeal Life Support376The retrospective analysis on 10 patients shows a 90% survival rate at 6 months, suggesting Aeson® as a therapeutic solution for these patients at risk of death in the short term. Regulatory News: CARMAT...
► Artikel lesen
31.03.CARMAT to Provide a Business Update and Host a Videoconference on April 9, 2025324Please register to the videoconference by clicking on one of the following links: Videoconference in French at 6:00 pm CEST - Videoconference in English at 8:00 pm CEST Regulatory News: CARMAT...
► Artikel lesen
27.03.CARMAT announces the implementation of a flexible equity financing line with IRIS Capital Investment435Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from...
► Artikel lesen
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3